Related Experiment Videos
[Hormone replacement therapy and ovarian tumors]
Ceska Gynekologie
|May 4, 2002
Summary
Hormone replacement therapy is not a confirmed risk factor for ovarian cancer. It can be safely used as supportive care for many patients undergoing ovarian cancer treatment.
Area of Science:
- Gynecologic Oncology
- Reproductive Endocrinology
Context:
- Ovarian cancer etiology and pathogenesis.
- Role of hormone replacement therapy (HRT).
Purpose:
- Analyze risk and protective factors in ovarian cancer.
- Evaluate HRT's role in ovarian cancer etiology and treatment.
Summary:
- Epidemiological studies reviewed.
- HRT's role as an ovarian cancer risk factor remains unconfirmed.
- HRT is acceptable as supportive and symptomatic therapy for many ovarian cancer patients.
Impact:
- Informs clinical decisions regarding HRT use in ovarian cancer patients.
- Clarifies HRT's relationship with ovarian cancer risk.
- Supports evidence-based supportive care strategies.